FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045676810> ?p ?o ?g. }

• W2045676810 endingPage "648" @default.
• W2045676810 startingPage "645" @default.
• W2045676810 abstract "Abstract In a non‐life‐threatening disease such as psoriasis, treatment goals should be referred to the improvement in severity and extent of the disease and their impact on patients’ perceived health‐related quality of life (HRQoL), usually measured by the Dermatology Life Quality Index ( DLQI ). The ultimate goal of therapy is blanching, and an improvement of 90% or better ( PASI 90 response) with respect to baseline Psoriasis Area and Severity Index ( PASI ) is considered as treatment success by the European Medicines Agency. PASI 75 response has become accepted as a less stringent reasonable therapeutic goal, but absolute PASI values might provide a better benchmark, irrespective of baseline PASI . Anyway, objective measures of psoriasis involvement are clinically meaningful only if they correlate with significant improvements in DLQI , and especially with the achievement of a DLQI = 0–1 status, corresponding to lack of effect of the disease on patient's HRQoL. Even though PASI 75 response meets therapeutic expectations in most patients, PASI 90 response or better has a significantly higher impact on DLQI improvement and is associated with significantly higher DLQI = 0–1 response rates. The introduction of anti‐ IL 17 drugs in clinical practice bears the promise of achieving PASI 90 response or better in the majority of patients, and initial data suggest that the PASI 90 benchmark provides better discriminatory value as regards achievement of DLQI = 0–1 response. Further research is required to confirm the value of absolute PASI cut‐offs as a measure of therapeutic success independent of baseline and duration of treatment, and to develop newer, more practical and more accurate measures of psoriasis severity." @default.
• W2045676810 created "2016-06-24" @default.
• W2045676810 creator A5027590834 @default.
• W2045676810 date "2014-11-04" @default.
• W2045676810 modified "2023-10-18" @default.
• W2045676810 title "PASI90 response: the new standard in therapeutic efficacy for psoriasis" @default.
• W2045676810 cites W1548178271 @default.
• W2045676810 cites W1549365041 @default.
• W2045676810 cites W1580608335 @default.
• W2045676810 cites W1798097943 @default.
• W2045676810 cites W1835192352 @default.
• W2045676810 cites W1970580490 @default.
• W2045676810 cites W1973354423 @default.
• W2045676810 cites W1976599419 @default.
• W2045676810 cites W1996308907 @default.
• W2045676810 cites W2003027167 @default.
• W2045676810 cites W2010271323 @default.
• W2045676810 cites W2030298480 @default.
• W2045676810 cites W2032856893 @default.
• W2045676810 cites W2053582742 @default.
• W2045676810 cites W2057699446 @default.
• W2045676810 cites W2086813459 @default.
• W2045676810 cites W2092267860 @default.
• W2045676810 cites W2093240740 @default.
• W2045676810 cites W2095297002 @default.
• W2045676810 cites W2152262899 @default.
• W2045676810 doi "https://doi.org/10.1111/jdv.12817" @default.
• W2045676810 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25370811" @default.
• W2045676810 hasPublicationYear "2014" @default.
• W2045676810 type Work @default.
• W2045676810 sameAs 2045676810 @default.
• W2045676810 citedByCount "148" @default.
• W2045676810 countsByYear W20456768102015 @default.
• W2045676810 countsByYear W20456768102016 @default.
• W2045676810 countsByYear W20456768102017 @default.
• W2045676810 countsByYear W20456768102018 @default.
• W2045676810 countsByYear W20456768102019 @default.
• W2045676810 countsByYear W20456768102020 @default.
• W2045676810 countsByYear W20456768102021 @default.
• W2045676810 countsByYear W20456768102022 @default.
• W2045676810 countsByYear W20456768102023 @default.
• W2045676810 crossrefType "journal-article" @default.
• W2045676810 hasAuthorship W2045676810A5027590834 @default.
• W2045676810 hasConcept C126322002 @default.
• W2045676810 hasConcept C159110408 @default.
• W2045676810 hasConcept C16005928 @default.
• W2045676810 hasConcept C2776173921 @default.
• W2045676810 hasConcept C2777011040 @default.
• W2045676810 hasConcept C2779951463 @default.
• W2045676810 hasConcept C2780564577 @default.
• W2045676810 hasConcept C71924100 @default.
• W2045676810 hasConceptScore W2045676810C126322002 @default.
• W2045676810 hasConceptScore W2045676810C159110408 @default.
• W2045676810 hasConceptScore W2045676810C16005928 @default.
• W2045676810 hasConceptScore W2045676810C2776173921 @default.
• W2045676810 hasConceptScore W2045676810C2777011040 @default.
• W2045676810 hasConceptScore W2045676810C2779951463 @default.
• W2045676810 hasConceptScore W2045676810C2780564577 @default.
• W2045676810 hasConceptScore W2045676810C71924100 @default.
• W2045676810 hasIssue "4" @default.
• W2045676810 hasLocation W20456768101 @default.
• W2045676810 hasLocation W20456768102 @default.
• W2045676810 hasOpenAccess W2045676810 @default.
• W2045676810 hasPrimaryLocation W20456768101 @default.
• W2045676810 hasRelatedWork W1752862699 @default.
• W2045676810 hasRelatedWork W1978428707 @default.
• W2045676810 hasRelatedWork W1991042891 @default.
• W2045676810 hasRelatedWork W2461170543 @default.
• W2045676810 hasRelatedWork W2462324581 @default.
• W2045676810 hasRelatedWork W2998923669 @default.
• W2045676810 hasRelatedWork W3091437709 @default.
• W2045676810 hasRelatedWork W4245009736 @default.
• W2045676810 hasRelatedWork W4247679967 @default.
• W2045676810 hasRelatedWork W4321997075 @default.
• W2045676810 hasVolume "29" @default.
• W2045676810 isParatext "false" @default.
• W2045676810 isRetracted "false" @default.
• W2045676810 magId "2045676810" @default.
• W2045676810 workType "article" @default.